Medical Bulletin 3/December/2021

Here are Top Medical stories of the day

Bicalutamide reduces hypertrichosis

A recent study has in the Journal of the American Academy of Dermatology has suggested that the addition of bicalutamide to oral minoxidil may improve minoxidil–induced hypertrichosis.

The combination of low-dose systemic minoxidil with antiandrogen therapy has been used for the treatment of female pattern hair loss (FPHL). Although minoxidil is shown to have a favorable safety profile, hypertrichosis occurs in up to 24% of patients. Bicalutamide is a pure, non-steroidal androgen receptor inhibitor that has been successfully used for FPHL treatment. Low-dose bicalutamide (25mg/daily) has also been used to treat moderate to severe hirsutism with significant efficacy.

For more details, check out the full story on the link below:

Bicalutamide May Reduce Minoxidil-Induced Hypertrichosis In Female Pattern Hair Loss: Study

T2D common in psychiatric patients

The prevalence of type 2 diabetes (T2D) is elevated in people with a psychiatric disorder compared with the general population, reveals a new research. The research was conducted by Nanna Lindekilde, Department of Psychology, University of Southern Denmark, Odense, Denmark, and colleagues.

The study has been published in the journal Diabetologia (the journal of the European Association for the Study of Diabetes (EASD)).

For more details, check out the full story on the link below:

Prevalence Of Type 2 Diabetes Elevated In Patients Of Common Psychiatric Disorders

Dental implant maintenance tied to peri- implantitis

Antiviral treatment reduces liver cancer progression

Hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) is a disease with a high recurrence rate.

Researchers at the Osaka City University Graduate School of Medicine reported in a new cohort study that in patients of HCC after receiving cancer treatment, the oral administration of direct-acting antivirals (DAA) reduces the risk of tumor progression following recurrence of the liver disease.

For more details, check out the full story on the link below:

Antiviral Treatment For Hepatitis C Reduces Risk Of Post-Treatment Liver Cancer Progression, Study Shows

Thoracoscopy- safe surgical option

Esophageal atresia (EA) and tracheoesophageal fistula (TEF) is one of the most common congenital malformations of the esophagus, with an incidence of 1/2500–1/4500.

Recent study findings suggest that thoracoscopy surgery is safe and effective surgical option for patients with Gross type C Esophageal atresia (EA) and tracheoesophageal fistula (TEF). The study findings were published in the journal BMC Surgery on November 22, 2021.

For more details, check out the full story on the link below:

Thoracoscopy Safe Surgical Option For Gross Type C Esophageal Atresia: Study